These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6816154)

  • 1. Histocompatibility antigens in patients with ectopic ossification due to fibrodysplasia ossificans progressiva.
    Connor JM; Woodrow JC; Evans DA
    Ann Rheum Dis; 1982 Dec; 41(6):646-7. PubMed ID: 6816154
    [No Abstract]   [Full Text] [Related]  

  • 2. Hematopoietic stem-cell contribution to ectopic skeletogenesis.
    Kaplan FS; Glaser DL; Shore EM; Pignolo RJ; Xu M; Zhang Y; Senitzer D; Forman SJ; Emerson SG
    J Bone Joint Surg Am; 2007 Feb; 89(2):347-57. PubMed ID: 17272450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leukocyte antigen B27 allele is not correlated with fibrodysplasia ossificans progressiva.
    Calvert GT; Shore EM
    Clin Orthop Relat Res; 1998 Jan; (346):66-70. PubMed ID: 9577412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute lymphocytic infiltration in an extremely early lesion of fibrodysplasia ossificans progressiva.
    Gannon FH; Valentine BA; Shore EM; Zasloff MA; Kaplan FS
    Clin Orthop Relat Res; 1998 Jan; (346):19-25. PubMed ID: 9577406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrodysplasia ossificans progressiva: a current review of imaging findings.
    Bauer AH; Bonham J; Gutierrez L; Hsiao EC; Motamedi D
    Skeletal Radiol; 2018 Aug; 47(8):1043-1050. PubMed ID: 29445932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. A study of forty-four patients.
    Cohen RB; Hahn GV; Tabas JA; Peeper J; Levitz CL; Sando A; Sando N; Zasloff M; Kaplan FS
    J Bone Joint Surg Am; 1993 Feb; 75(2):215-9. PubMed ID: 8423182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-COVID-19 exacerbation of fibrodysplasia ossificans progressiva with multiple flare-ups and extensive heterotopic ossification in a 45-year-old female patient.
    Grgurevic L; Novak R; Hrkac S; Salai G; Grazio S
    Rheumatol Int; 2021 Aug; 41(8):1495-1501. PubMed ID: 34110466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomalignant heterotopic ossification.
    Kaplan FS; Gannon FH; Hahn GV; Wollner N; Prauner R
    Clin Orthop Relat Res; 1998 Jan; (346):134-40. PubMed ID: 9577421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe restriction in jaw movement after routine injection of local anesthetic in patients who have fibrodysplasia ossificans progressiva.
    Luchetti W; Cohen RB; Hahn GV; Rocke DM; Helpin M; Zasloff M; Kaplan FS
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Jan; 81(1):21-5. PubMed ID: 8850477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation in Fibrodysplasia Ossificans Progressiva and Other Forms of Heterotopic Ossification.
    Matsuo K; Chavez RD; Barruet E; Hsiao EC
    Curr Osteoporos Rep; 2019 Dec; 17(6):387-394. PubMed ID: 31721068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myositis ossificans in children: a review.
    Sferopoulos NK; Kotakidou R; Petropoulos AS
    Eur J Orthop Surg Traumatol; 2017 May; 27(4):491-502. PubMed ID: 28275867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristic calcaneal ossification: an additional early radiographic finding in infants with fibrodysplasia ossificans progressiva.
    Hasegawa S; Victoria T; Kayserili H; Zackai E; Nishimura G; Haga N; Nakashima Y; Miyazaki O; Kitoh H
    Pediatr Radiol; 2016 Oct; 46(11):1568-72. PubMed ID: 27492340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterotopic ossification in fibrodysplasia ossificans progressiva.
    Sharma A; Behar M
    J Pediatr; 2015 Jan; 166(1):204. PubMed ID: 25444017
    [No Abstract]   [Full Text] [Related]  

  • 14. Hints on transcriptional control of essential players in heterotopic ossification of Fibrodysplasia Ossificans Progressiva.
    Ravazzolo R; Cappato S; Bocciardi R
    Bone; 2018 Apr; 109():187-191. PubMed ID: 29100956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granting immunity to FOP and catching heterotopic ossification in the Act.
    Kaplan FS; Pignolo RJ; Shore EM
    Semin Cell Dev Biol; 2016 Jan; 49():30-6. PubMed ID: 26706149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cumulative analogue joint involvement scale (CAJIS) for fibrodysplasia ossificans progressiva (FOP).
    Kaplan FS; Al Mukaddam M; Pignolo RJ
    Bone; 2017 Aug; 101():123-128. PubMed ID: 28465250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrodysplasia ossificans progressiva: a case report.
    Dhamangaonkar AC; Tawari AA; Goregaonkar AB
    J Orthop Surg (Hong Kong); 2013 Dec; 21(3):383-6. PubMed ID: 24366806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA and myositis ossificans circumscripta.
    Kriegbaum NJ; Lundberg D; Pedersen W; Jakobsen BK
    Scand J Rheumatol; 1986; 15(3):352. PubMed ID: 3798051
    [No Abstract]   [Full Text] [Related]  

  • 19. Fibrodysplasia (myositis) ossificans progressiva. Clinical lessons from a rare disease.
    Smith R
    Clin Orthop Relat Res; 1998 Jan; (346):7-14. PubMed ID: 9577404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrodysplasia Ossificans Progressiva: A Case Report.
    Acharya S; Joshi S; Chaulagain R
    J Nepal Health Res Counc; 2018 Jul; 16(2):245-247. PubMed ID: 29983445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.